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CGG repeat expansions in the Fragile X mental retardation 1 (FMR1) gene are
responsible for a family of associated disorders characterized by either intellectual
disability and autism Fragile X Syndrome (FXS), or adult-onset neurodegeneration
Fragile X-associated Tremor/Ataxia Syndrome. However, the FMR1 locus is complex
and encodes several long non-coding RNAs, whose expression is altered by repeat
expansion mutations. The role of these lncRNAs is thus far unknown; therefore we
investigated the functionality of FMR4, which we previously identified. “Full”-length
expansions of the FMR1 triplet repeat cause silencing of both FMR1 and FMR4, thus
we are interested in potential loss-of-function that may add to phenotypic manifestation
of FXS. Since the two transcripts do not exhibit cis-regulation of one another, we
examined the potential for FMR4 to regulate target genes at distal genomic loci
using gene expression microarrays. We identified FMR4-responsive genes, including
the methyl-CpG-binding domain protein 4 (MBD4). Furthermore, we found that in
differentiating human neural precursor cells, FMR4 expression is developmentally
regulated in opposition to expression of both FMR1 (which is expected to share a
bidirectional promoter with FMR4) and MBD4. We therefore propose that FMR4’s
function is as a gene-regulatory lncRNA and that this transcript may function in normal
development. Closer examination of FMR4 increases our understanding of the role of
regulatory lncRNA and the consequences of FMR1 repeat expansions.
Keywords: lncRNA, intellectual disability, epigenetics, differentiation, chromatin remodeling, MBD4, FMR4,
Fragile X
Abbreviations: ASD, autism spectrum disorder; DIV, days in vitro; FMRP, Fragile X mental retardation protein; FXPOI,
Fragile X-related primary ovarian insuﬃciency; FXS, Fragile X syndrome; FXTAS, Fragile X-associated tremor/ataxia
syndrome; hNPCs, human neural precursor cells; hNS, human neurospheres; lncRNAs, long non-coding RNAs; mRNA,
messenger RNA; ncRNAs, non-coding RNAs.
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Introduction
Fragile X Syndrome, FXTAS, and FXPOI are X-linked disorders
that arise from expansions in a CGG-repeat region in the
5′-UTR of the FMR1 gene. Normal FMR1 alleles contain 6–
54 repeats, expansions from 55 to 200 repeats are considered
“premutations” and all larger repeat sizes are known as
the “full mutations.” Individuals with a premutation may
develop the adult-onset neurodegenerative disorder known as
FXTAS, while women carrying the premutation are at risk
for FXPOI. Only the full mutation leads to FXS, which is a
common cause of inherited intellectual disability and autism
(Oostra and Willemsen, 2003). FMR1 premutations result in
overproduction of toxic, expanded mRNAs that contribute to
the development of FXPOI and FXTAS pathology (Tassone
et al., 2000; Kenneson et al., 2001). Full mutations lead to
DNA and repressive histone methylation of the FMR1 locus
(Sutcliﬀe et al., 1992; Hornstra et al., 1993; Coﬀee et al., 1999,
2002; Kumari and Usdin, 2010). Thus FXS derives from the
loss of FMR1 mRNA and protein FMRP. We and others have
identiﬁed four non-coding transcripts with abnormal expression
in response to Fragile X repeat expansions at the FMR1 locus
(Ladd et al., 2007; Khalil et al., 2008; Pastori et al., 2014),
but their role in FXS/FXTAS/FXPOI phenotypes remains to be
determined.
The vast majority of the human transcriptome is comprised
of either long [>200 nucleotides (nt)] or short ncRNAs
(Cheng et al., 2005; Banfai et al., 2012; Djebali et al.,
2012). While short ncRNAs typically regulate gene expression
through posttranscriptional mechanisms or by interfering with
translation (Rother and Meister, 2011; Fabian and Sonenberg,
2012), lncRNAs (which can be many kilobases long) often act in
cis or trans to regulate gene expression at their locus of origin
or elsewhere in the genome, respectively. Evidence suggests
that lncRNAs perform scaﬀolding functions by recruiting
epigenetic complexes or ribonucleoproteins that cause chromatin
remodeling (Wang and Chang, 2011). Other lncRNAs act post-
transcriptionally by targeting mRNAs or translational machinery.
Regardless of the mechanism, a growing body of evidence
implicates lncRNAs in a myriad of normal cellular functions
such as DNA damage response and mitosis (Tsai et al., 2010;
Yap et al., 2010; Hung et al., 2011; Kotake et al., 2011; Wang
and Chang, 2011) and in diseases, such as cancer (Hajjari et al.,
2014).
Recent attention has focused more speciﬁcally on the role
of lncRNAs in neurodevelopmental programs and diseases of
the nervous system. For example, lncRNAs are involved in
the diﬀerentiation of neural cell types, and synaptic signaling
and maturation (Mercer et al., 2010; Qureshi et al., 2010). In
addition, both short and long ncRNAs are known to be involved
in Prader–Willi syndrome, which is a developmental disorder
caused by paternal deletion of a maternally imprinted region
and can present with metabolic dysregulation including circadian
rhythm defects (Sahoo et al., 2008; De Smith et al., 2009;
Powell et al., 2013). Both syndromic and non-syndromic ASD
susceptibility loci also contain aberrantly expressed lncRNAs
that may contribute to disease (Velmeshev et al., 2013; Ziats
and Rennert, 2013). Dysfunction of lncRNAs has also been
linked to pathogenesis of neurodegenerative disorders including
Alzheimer’s disease (Faghihi et al., 2008) and spinocerebellar
ataxia type 7, another repeat expansion disorder (Sopher et al.,
2011). In sum, there is a growing body of evidence supporting the
involvement lncRNAs in both the normal and diseased nervous
system, spurring further mechanistic inquiries.
FMR4, an untranslated, antisense lncRNA originating at the
FMR1 gene locus was shown to have anti-apoptotic functions in
HEK293T and HeLa cells but to have no eﬀect on expression of
FMR1 (Khalil et al., 2008). Here, we describe FMR4’s function
as a regulator of gene expression in trans by identifying mRNA
expression changes induced by FMR4. In particular, these eﬀects
in HEK293T cells are mirrored by discordant developmental
regulation between FMR4 and one of its targets, MBD4, in
hNPCs.
Materials and Methods
HEK293T Cell Culture, Transfection, and RNA
Extraction
HEK293T cells were cultured in DMEM with 10% FBS.
In overexpression experiments, cells were transfected with
pcDNA3.1-FMR4 or the empty pcDNA3.1 control vector
using Lipfectamine 2000CD. For knockdown experiments, the
siRNA FMR4(C) (Khalil et al., 2008), versus Silencer Negative
Control siRNA #1 (Ambion) were used with the Lipofectamine
RNAiMAX transfection reagent, according to manufacturer’s
instructions (Invitrogen). For microarray experiments, 1 × 106
cells were plated and transfected with 0.5 µg plasmid or
40 nM siRNA on the same day, and incubated for 6 or 24 h
after transfection. For validation, FMR4 was knocked down
using two sequential siRNA transfections over 72 h. RNA was
extracted using Trizol (Invitrogen) and the RNeasy Mini Kit, and
treated with DNAse on-column using the RNAse-free DNAse Set
(Qiagen) according to manufacturer’s instructions.
Microarray Hybridization and Analysis
At 6 or 24 h post transfection, RNA was extracted and
samples were submitted to the Hussman Institute for Human
Genomics Center for Genome Technology for microarray
analysis using Aﬀymetrix Human Gene 2.0 ST Arrays. Total
RNA samples were ﬁrst prepared using the Ambion WT
Expression Kit (cat# 4411974). Brieﬂy, the kit generates sense-
strand cDNA from total RNA using a reverse transcription
priming method that speciﬁcally primes non-ribosomal
RNA, including both poly(A) and non-poly(A) mRNA. Next,
samples are fragmented and labeled using the Aﬀymetrix
GeneChip WT Terminal Labeling Kit (cat# 902280). Final
yield was hybridized onto the array, washed and stained
using the Aﬀymetrix GeneChip Hybridization, Wash, and
Stain Kit (cat# 900720). Arrays were scanned using GeneChip
Scanner 3000 7G system. Background subtraction, GC-RMA
normalization and quality control were performed using the
Aﬀymetrix GeneChip Command Console Software and the
bioconductor package from R. Data have been archived in
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the Gene Expression Omnibus at the National Center for
Biotechnology Information, and assigned the accession number
GSE70817.
cDNA Synthesis and Quantitative Real-Time
PCR (qPCR)
cDNA was synthesized using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) with 500 ng of total
RNA per reaction. Gene-speciﬁc FMR4 cDNA was primed
separately (“FMR4 RT”: ATTGCTGGCAGTCGTTTCTT), in
order to speciﬁcally detect the antisense transcript and prevent
capture of overlapping sense transcripts arising from that
genomic region. Random hexamer-primed cDNA libraries were
used for detection of all other genes. FMR4 RNA expression
was quantiﬁed using SYBR Green quantitative real-time PCR
(qPCR) with the following primers, validated by melting
curve: “FMR4 FW” – ACCAAACCAAACCAAACCAA and
“FMR4 REV” – GTGGGAAATCAAATGCATCC. Commercially
available TaqMan probes (Invitrogen) were used for all
other transcripts (MBD4, cat# Hs00187498_m1; FMR1,
cat# Hs00924547_m1; MALAT1, cat# Hs01910177_s1).
The endogenous control was glyceraldehyde 3-phosphate
dehydrogenase (GAPDH, cat# 4326317E) where necessary,
and data were analyzed by the Ct method. For polyA
detection, cDNA was synthesized from 1 µg total RNA
using the High Capacity cDNA kit and oligodT primers at
50 nM ﬁnal concentration. In the noRT control, we omitted
the reverse-transcriptase enzyme from the cDNA synthesis
reaction. Reverse transcription products were ampliﬁed
using qPCR as described above and visualized on a 1.5%
agarose gel.
Human Neural Precursor Cell (hNPC) Culture,
Differentiation, and Viral Transduction
hNPCs used in this study were derived from human fetal
brains collected from third trimester aborted fetuses received
from the Birth Defects Research Lab at the University of
Washington in Seattle. This work was classiﬁed as “Non-
Human Subject Research” by the Human Subject Research Oﬃce
at the University of Miami, and therefore was not subject
to Institutional Review Board approval. Brieﬂy, brain tissues
were dissected and dissociated using the trypsin-based Neural
Tissue Dissociation Kit (Miltenyi Biotec, cat #130-093-231).
Five million single cells were seeded into each 75-mm tissue
culture ﬂask in proliferation media supplemented with B27
(1X of proprietary formula), human Epidermal Growth Factor
(hEGF) at 20 ng/mL, human Fibroblast Growth Factor (hFGF)
at 10 ng/mL, heparin at 20 ug/mL, GlutaMax (1X, Gibco),
and Primocin at 0.1 mg/mL (InvivoGen). Neural stem cells
formed neurosphere colonies after approximately 7 DIV, while
other cells remained in suspension as single cells or formed a
monolayer on the ﬂask surface. Neurospheres can be maintained
as such in suspension for several months using proliferation
media, or hNPCs can be diﬀerentiated, forming a mixture of
neurons and astrocytes. Neurospheres were transduced with a
lentiviral vector expressing FMR4 (pLentiCMV/TO-mCherry-
FMR4) or the control vector (pLentiCMV/TO-mCherry), and
collected for qPCR analysis after 2 days. To diﬀerentiate,
neurospheres are dissociated into single cells with Accutase
and cultured in Advanced DMEM/F12 media without hFGF
or hEGF, but with Bottenstein’s N2 at 1X (Invitrogen,
proprietary formula), 2.5% fetal bovine serum, heparin at
20 µg/mL, GlutaMax (1X, Gibco) and Primocin at 0.1 mg/mL
(InvivoGen).
Subcellular Fractionation
Neurospheres were collected by centrifugation at 250 × g in
order to form 50 µL pellets. Pellets were washed with PBS
and fractionated with the NE-PER Nuclear and Cytoplasmic
Extraction Reagents (Thermo Scientiﬁc, cat# 78835) according to
manufacturer’s instructions. Brieﬂy, cells were sequentially lysed
and centrifuged to ﬁrst separate pelleted nuclei from cytoplasm,
then to separate chromatin from nucleoplasmic components.
RNAwas extracted from solid chromatin with 1mL of Trizol, and
with 0.75mL Trizol LS for every 0.25mL of liquid fraction. cDNA
prepared using random primers was used for TaqMan qPCR
(MALAT1, GAPDH, and FMR1), while gene-speciﬁc priming and
SYBR Green was used for FMR4 as noted above. In each case,
starting material for cDNA reactions was 2 µL total RNA (not
equal mass of RNA), to enable comparison of absolute quantities
of each transcript between compartments. Relative quantiﬁcation
(RQ) for each transcript in each compartment was calculated
from Cq values by qPCR. Individual fraction RQ values were
normalized to the total detected amount for each transcript.
Results
Fmr4 Induces Genome-Wide Changes in Gene
Expression
Previous studies of the 2.4 kb antisense lncRNA FMR4
described no cis-regulation of FMR1 (Khalil et al., 2008);
therefore we hypothesized that FMR4 would regulate gene
expression in trans, which is a well-documented function
of other lncRNAs (Rinn et al., 2007; Kino et al., 2010;
Miyagawa et al., 2012). In order to comprehensively measure
gene regulation in response to FMR4 at the mRNA level, we
treated HEK293T cells with either an siRNA against FMR4, a
scrambled control siRNA (knockdown), pcDNA3.1-FMR4, or
the empty pcDNA3.1 vector (overexpression) and processed for
microarray hybridization after 6 or 24 h. Using LIMMA, a linear
modeling approach (Smyth, 2004), we identiﬁed diﬀerential
expression of over 3,700 genes between FMR4 knockdown,
overexpression and their respective control conditions, and
characterized the pattern of target gene expression relative
to FMR4. To this end, we used the Cluster Aﬃnity tool
of TIGR MultiExperiment Viewer to identify genes with
opposite behavior in the knockdown condition compared
to the overexpression condition. This strategy narrowed our
focus to the 238 transcripts represented in Figure 1A and
Supplementary Figure S1, which are further classiﬁed by
whether they are concordant or discordant with respect to
FMR4 changes. This analysis yielded 155 and 83 target genes
with concordant and discordant changes in mRNA expression
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FIGURE 1 | Microarray analysis of mRNA expression changes in
response to FMR4 knockdown and overexpression reveal
trans-regulatory targets. (A) Microarray analysis of HEK293T cells with FMR4
overexpression or knockdown (n = 3). LIMMA analysis and Cluster Affinity
identified genes concordantly or discordantly regulated compared to FMR4.
(B) FMR4 was knocked down with siRNA in HEK293T cells in order to validate
changes in a putative FMR4-sensitive gene identified by microarray (C). (n = 6,
∗p < 0.05 by Student’s t-test).
relative to FMR4, respectively. These data support the idea
that FMR4 is a regulator of gene expression through trans-
activity.
Pathway Analysis and FMR4 Target Validation
We then analyzed the cohort of concordant and discordant
FMR4-responsive genes with GeneGo Metacore (Tables 1 and
2). Cell cycle regulation and apoptosis were highly ranked
biological processes aﬀected by FMR4, which is consistent
with our earlier ﬁndings (Khalil et al., 2008). Additionally,
FMR4-sensitive genes are enriched in developmental
processes in general and neurodevelopmental processes
in particular (e.g., adrenergic and opioid signaling, Wnt
pathway, cytoskeletal elements, synaptogenesis). Informed
by the pathway analysis and previous insights into FMR4’s
function, we used HEK293T cells with FMR4 knocked down
by sequential siRNA transfections (Figure 1B) to validate
a 28% increase in methyl CpG-binding domain (MBD4;
Figure 1C).
Developmental Regulation of Gene Expression
by FMR4 in hNPCs
To investigate the putative role of FMR4 in neurodevelopment
and Fragile X-associated neurological disorders, we used an
in vitro model system consisting of human fetal-derived
neurospheres (hNSs). These cells can be maintained as precursor
in hNSs, or induced to diﬀerentiate into a mixed culture of
early neurons and glia (see Materials and Methods). This system
has the advantage of being a primary culture of human brain
cells (critical for studying a primate-speciﬁc transcript in vitro)
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TABLE 1 | Top GeneGo pathways represented by FMR4-responsive genes
identified by microarray analysis.
Category GeneGo pathway p-value
Cell adhesion Chemokines and adhesion 0.10161
Integrin-mediated cell adhesion and
migration
0.11458
Cell cycle Regulation of G1/S transition (part 2) 0.00000
Nucleocytoplasmic transport of
CDK/Cyclins
0.03480
Spindle assembly and chromosome
separation
0.08019
Development Mu-type opioid receptor signaling via
beta-arrestin
0.00000
S1P1 receptor signaling via
beta-arrestin
0.00000
Beta-adrenergic receptors
transactivation of EGFR
0.00000
Ligand-independent activation of ESR1
and ESR2
0.00001
Gastrin in cell growth and proliferation 0.00002
Alpha-2 adrenergic receptor activation
of ERK
0.00002
Regulation of
epithelial-to-mesenchymal transition
(EMT)
0.04670
Lipoxin inhibitory action on PDGF, EGF,
and LTD4 signaling
0.08717
A3 receptor signaling 0.11683
Immune response Oncostatin M signaling via MAPK in
mouse cells
0.00000
Oncostatin M signaling via MAPK in
human cells
0.00000
IL-15 signaling 0.00002
Histamine H1 receptor signaling in
immune response
0.02758
Transport RAN regulation pathway 0.04453
N/A Inhibitory action of Lipoxin A4 on PDGF,
EGF, and LTD4 signaling
0.08485
without the need for reprogramming, as would be the case with
embryonic or induced pluripotent stem cells. We focused on
the relationship between FMR4 and its putative target gene,
MBD4, which we identiﬁed by microarray analysis. MBD4 is
a transcriptional repressor involved in DNA repair (Ballestar
and Wolﬀe, 2001; Kondo et al., 2005). Expression of MBD4
developmentally regulates several tissues (Ruddock-D’cruz et al.,
2008; Zhang et al., 2014a), and its aberrant expression in
hippocampal GABAergic neurons in psychiatric disease may be
linked to abnormal diﬀerentiation in these cells (Benes et al.,
2009).
The FMR1 locus is crucial to normal brain development;
thus, we wanted to determine whether FMR4 expression is
dependent on developmental stage. We extracted RNA from
undissociated hNS [“0 days in vitro” (DIV)] and cultured cells
from dissociated hNS up to ﬁve DIV in diﬀerentiation media.
At both time points, we measured FMR4 expression as well
as that of FMR1, to determine whether these transcripts are
independently regulated. We observed that FMR4 expression
TABLE 2 | Top GeneGo process networks represented by
FMR4-responsive genes identified by microarray analysis.
Category GeneGo process networks p-value
Apoptosis Death domain receptors and caspases
in apoptosis
0.02682
Cell adhesion Platelet aggregation 0.02999
Leucocyte chemotaxis 0.04076
Cell cycle G1/S Interleukin regulation 0.00000
G1-S Growth factor regulation 0.00002
Cytoskeleton Actin filaments 0.00022
Actin filaments 0.03088
Development Hemopoiesis, erythropoietin pathway 0.00000
Neurogenesis and synaptogenesis 0.08499
Neuromuscular junction 0.11290
Wnt/beta-catenin, notch, VEGF, IP3,
and integrin signaling
0.11674
DNA Damage Checkpoint 0.00006
Immune response BCR pathway 0.00008
Inflammation MIF signaling 0.00000
IL-2 signaling 0.00003
Protein C signaling 0.06668
Kallikrein–kinin system 0.09179
Reproduction FSH-beta signaling pathway 0.00001
Signal CREM pathway 0.00002
Transduction Neuropeptide signaling pathways 0.01407
is signiﬁcantly decreased in diﬀerentiating cells at 5 DIV while
FMR1 is increased at the same time point (Figure 2A). We
then measured MBD4 and found that it is also developmentally
regulated. As indicated by the microarray analysis, MBD4
was increased at a time point when FMR4 expression is low
(Figure 2A). We also observed changes in expression level
of other FMR4 target genes in undiﬀerentiated, proliferating
hNPCs transduced with an mCherry-tagged lentiviral vector
expressing FMR4 (Supplementary Figure S2A). We found
that FMR4 overexpression signiﬁcantly upregulated two
putative targets, the deubiquitinase YOD1 and the G-protein
subunit GNG12, and downregulated the ribonucleotide
reductase RRM2 (Supplementary Figure S2B). These data
corroborate our ﬁnding that FMR4 regulates gene expression in
trans.
Molecular Mechanisms of FMR4
To better understand the molecular role of FMR4, we performed
subcellular fractionation of hNS. As expected, GAPDH and
FMR1 mRNA were highest in the cytoplasmic fraction (87.6 and
67.0%, respectively) where they are translated (Duszczyk et al.,
2011) (Figure 2B). Some lncRNAs are expressed predominantly
in the nucleus. A well-known example of this is the lncRNA
NEAT2/MALAT1 (Gutschner et al., 2013). We measured this
transcript as a positive control for nuclear transcripts, and
found it enriched in the nucleoplasm (41.6%) and chromatin
(54.0%) relative to the cytoplasm (Figure 2C). FMR4 RNA
was primarily localized (73.4%) to chromatin (Figure 2C),
which is consistent with a transcriptional regulatory function of
FMR4.
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FIGURE 2 | Expression of FMR4 and its target MBD4 during
differentiation of hNPCs may be related to chromatin-modulatory
function of the lncRNA. (A) Comparison of RNA expression between
proliferating neurospheres (0 DIV) and differentiating hNPCs (5 DIV) revealed
increased FMR1 and decreased FMR4 after 5 days of differentiation (n = 5,
∗p < 0.05 by Student’s t-test). As predicted, the putative FMR4 target gene
MBD4 was upregulated with decreased FMR4. Subcellular fractionation of
hNPCs with subsequent qPCR detection confirmed the cytoplasmic
localization of mRNAs such as (B) GAPDH and FMR1. MALAT1 (C), known to
be associated to nuclear speckles, was significantly enriched in the nucleus
and chromatin compared to cytoplasm. FMR4 RNA (C) was largely localized
to chromatin. (n = 5, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 by One-way
ANOVA with Tukey HSD).
Since RNA polyadenylation frequently targets mature
RNA for export into the cytoplasm (Zhang et al., 2014b);
many lncRNAs are not polyadenylated. Therefore, to establish
whether FMR4 can be polyadenylated, we performed ﬁrst-strand
cDNA synthesis with oligodT primers, thereby capturing
polyadenylated transcripts from total hNS RNA. We observed
via qPCR that in addition to FMR1 and GAPDH mRNAs
(which are expected to be polyadenylated), a detectable portion
of FMR4 is also polyadenylated (Supplementary Figure S3).
These data suggest that a fraction of FMR4 may be stabilized by
polyadenylation; this would increase the molecule’s half-life and
permit its diﬀusion to distant genomic loci.
Discussion
Loss of FMR1 mRNA and FMRP function has been widely
studied, but there is relatively little known about ncRNA
encoded by the locus. Here we show that one such ncRNA,
FMR4, may regulate mRNA expression genome-wide via a
developmentally regulated transcriptional mechanism, thereby
impacting important biological processes.
Similar to FMR4, trans-acting lncRNAs [such as HOTAIR,
MALAT1, and GAS5 (Rinn et al., 2007; Kino et al., 2010;
Miyagawa et al., 2012)] aﬀect loci far from their genomic locus
of origin. In this study, we conﬁrmed that knockdown and
overexpression of FMR4 causes changes in genes involved in
proliferation and diﬀerentiation. As a chromatin-associated
transcript, FMR4 may act at the transcriptional level by
forming complexes with histone modifying enzymes or
by directly targeting mRNA stability, splicing, or editing.
It remains to be seen whether these observations are
dependent on RNA-protein interactions, and whether they
result from direct epigenetic changes or via downstream
eﬀects.
Our data show that FMR4 is developmentally regulated
in an hNPC model. After 5 days of in vitro diﬀerentiation,
FMR4 expression is signiﬁcantly reduced, while that of both
FMR1 and the FMR4 target gene MBD4 is increased. Since
FMR4 and FMR1 do not interact in cis but are discordantly
expressed with diﬀerentiation of hNPCs, the bidirectional
promoter responsible for expression of both of these transcripts
might be activated in only one direction at a time. An
alternative possibility is that FMR4 RNA is degraded at a
higher rate during this period while FMR1 is not. Nevertheless,
it would be interesting to determine whether transcription
factors normally regulate this locus as a whole or target each
transcript individually. It is also unclear whether the decrease
in FMR4 lncRNA expression contributes to disease in addition
to loss of FMR1, or is an artifact of the locus-wide, full
mutation-induced epigenetic changes causing transcriptional
repression. Future studies will be necessary to distinguish
between these possible mechanisms and consequences of FMR4
regulation.
Discordant regulation of MBD4 and FMR4 leads us to
conclude that FMR4 regulates expression of genes at distal loci,
as the same relationship was identiﬁed by our overexpression
and knockdown studies. Our independent validation studies
conﬁrm this was not due to false positive identiﬁcation,
which is a common problem in genome-wide analyses such
as microarray studies. FMR4’s localization to the chromatin
fraction points to a transcriptional mechanism for this eﬀect,
however, studies evaluating the direct binding of FMR4 to
nucleic acids or proteins are warranted. Such studies could
suggest a direct role for FMR4 in speciﬁcally regulating MBD4
and gene expression more broadly, although this cannot be
concluded deﬁnitively based solely on changes in mRNA
levels. We acknowledge that diﬀerences in RNA processing
or any number of eﬀects downstream of FMR4 could be
responsible for the observed diﬀerential gene expression,
therefore it would be useful to examine precise interactions
between FMR4 and its targets. Chromatin immunoprecipitation
experiments could, for example, establish an interaction between
FMR4 and promoter regions of target genes. Based on
the function of other lncRNAs, one could speculate that
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FMR4 helps form three-dimensional interactions between
distant sequence elements such as promoters and enhancers
(Ma et al., 2014), and that FMR4 polyadenylation targets
this transcript for further RNA processing (Norbury, 2013).
Answering these questions would help our understanding of
FMR4 function in particular and continue the rapid expansion
of evidence on the elements that govern lncRNA actions in
general.
In this study we have described novel facets of FMR4
functionality as it relates to neurodevelopment, and suggest
that perturbation in the expression of this lncRNA may
contribute to pathogenesis of the Fragile X repeat expansion-
associated disorders. We report that trans-regulatory activity
of FMR4 is corroborated by changes in target gene expression
during diﬀerentiation of hNPCs. With this new information,
we have further developed the evidence supporting the
role of primate-speciﬁc lncRNAs in complex developmental
programs and opened new avenues of research into the
causes and therapies for Fragile X-associated neurological
disorders.
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